Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Damora Therapeutics granted inducement stock options to two newly hired non-executive employees as a material inducement to employment. The grants cover an aggregate of 57,500 shares with a 10-year term and an exercise price of $25.66 per share.
Key figures
- Offering Price
- 25.66
- Shares Offered
- 57500
- Vesting schedule
- 25% on first anniversary, equal monthly installments for 36 months
- Options term years
- 10
- Grant recipient type
- non-executive employees
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.